Hospital del Mar Research Institute Hospital del Mar Research Institute

News / Institutional news

  • 22/12/2015 - Institutional news

    Job position of Research director of the MAR Health Park (PSMAR) of Barcelona

    Research director of the MAR Health Park of Barcelona who, associated with their research management role, will also have functions as director of the Hospital del Mar Medical Research Institute (IMIM).  

    Més informació "Job position of Research director of the MAR Health Park (PSMAR) of Barcelona"

  • 09/10/2015 - Institutional news

    IMIM receives funding from the IOC to conduct innovative anti-doping research

    In its mission to protect and promote clean athletes, the International Olympic Committee (IOC) is financing and backing seven innovative research projects in the fight against doping, which include a project by Dr Jordi Segura, coordinator of the research group on bioanalysis and analytic services at IMIM. The project is entitled ‘Developments for improving compliance with blood testing, a fundamental but minimally implemented tool in doping control (EASY BLOOD)’ and its purpose is to explore and validate the applicability of the use of new matrices (dried blood spot and capillary sampling) to replace the blood sample collection methods that are currently used to control doping (which are whole blood, plasma and serum). The seven projects funded are from Australia, Spain and the United Kingdom and were selected from among the applications received from throughout the world in the two calls opened by the IOC.

    Més informació "IMIM receives funding from the IOC to conduct innovative anti-doping research"

  • 29/06/2015 - Institutional news

    IMIM is awarded by the European Commission with the “HR Excellence in Research” logotype.

    Dated June 2015, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) has been recognized by the European Commission with the “HR Excellence in Research” award. This recognition highlights IMIM’s commitment towards adopting the general principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers (Charter&Code) and gives its full support to the improvement of human resources internal policies and procedures. This recognition of excellence is an opportunity to establish a global and cohesive human resources strategy which will allow for an international visibility provided by a stimulating work environment and favorable working conditions for research.

    Més informació "IMIM is awarded by the European Commission with the “HR Excellence in Research” logotype."

  • 17/12/2014 - Institutional news

    Rosa Ventura is the new director of the Anti-Doping Control Laboratory at IMIM

    As of January 1st, Dr. Rosa Ventura will be the new director of the Anti-Doping Control Laboratory at IMIM, replacing Dr. Jordi Segura who, after 30 years, is leaving the post to retire. However, until July 2016, Dr. Segura will remain at the Laboratory part-time supporting research and any other need that may arise. Since 1985, when the Laboratory gained accreditation from the International Olympic Committee (IOC), and later on from the World Anti-Doping Agency (WADA), Dr. Segura has been at the helm of the Laboratory, with a clear priority right from the start, that is to high quality and reliable services. A Laboratory that has been in charge of controls for important sports events such as the Barcelona Olympics and Paralympics in 1992; the Pan American Games in Havana in 1991; in Mar de Plata in 1995 and Mexico 2011; The Asian Games in Bangkok in 1998, or the FINA World Swimming Championships held in Barcelona in 2003 and 2013, as some of the most relevant ones. The Lab also collaborated in anti-doping controls for the Olympics during the past 25 years.

    Més informació "Rosa Ventura is the new director of the Anti-Doping Control Laboratory at IMIM"

  • 10/10/2014 - Institutional news

    Precipita platform presentation and the video game Brainful Legends

    The Science and Innovation Ministry through the Science and TechnologySpanish Foundation launched last October 9 at the headquarters of the Carlos III Institute thePrecipita platform, designed to promote special interesting projects to be funded through micro-patronage (crowdfunding), small contributions from individuals. One of the selected projects presented is Brainful Legends, a videogame for cognitive stimulation, science-based, modern, funny and, above all, accessible to all people with intellectual disabilities.

    Més informació "Precipita platform presentation and the video game Brainful Legends"

  • 07/05/2014 - Institutional news

    Anna Bigas chosen a member of the EMBO

    The European Molecular Biology Organization (EMBO) (link) has chosen 106 excelling researchers in the field of life sciences as new members of this prestigious organisation. Among these new members is Dr. Anna Bigas, the coordinator of the research group on stem cells and cancer at IMIM, and the only Spanish researcher chosen at this edition. This year’s edition has welcomed the largest number of researchers to celebrate the organization’s 50th anniversary. Out of the 106 scientists chosen, one hundred of them live in Europe and neighbour countries and six of them are associate members from China, Japan and the US. The EMBO currently has more than 1,600 scientists working in the field of life sciences, all of who have been chosen for their exceptional contributions to this field of science.

    Més informació "Anna Bigas chosen a member of the EMBO"

  • 09/09/2013 - Institutional news

    Advances in blood stem cell biology

    Researchers from the IMIM (Hospital del Mar Medical Research Institute) have proven that protein PARP2 plays a key role in maintaining the integrity of the genome of blood stem cells, also known as haematopoietic cells. These results may prove useful to design new drugs and to improve therapeutic strategies based on radiotherapy and chemotherapy. In human cells, cell activities and environmental factors may damage DNA causing up to a million lesions in a cell each day. These lesions can cause mutations that are potentially harmful for the cell’s genome, affecting the survival of “daughter cells”. The haematopoietic system dealing with the formation, development and maturation processes of blood cells is maintained thanks to a small number of stem cells in the bone marrow that are renewed indefinitely during life and lead to the creation of parent cells and all mature blood cells. An appropriate response to the damaged DNA is essential for the normal functioning of these cells and to avoid programmed cell death or the development of diseases such as cancer.

    Més informació "Advances in blood stem cell biology"

  • 20/12/2012 - Institutional news

    A delegation from the China Anti-Doping Agency visits IMIM

    On Friday the 14th of December, the Bioanalysis and Analytical Services Research Group from IMIM (Hospital del Mar Medical Research Institute) was visited by a delegation from the China Anti-Doping Agency (CHINADA). This visit is framed within the longstanding collaboration between the Anti-Doping Control Laboratory and IMIM and the Beijing Anti-Doping Laboratory and the China Anti-Doping Agency for research projects on doping control in sports.

    Més informació "A delegation from the China Anti-Doping Agency visits IMIM"

  • 19/12/2011 - Institutional news

    Andrea Cerutti obtains the ERC Advanced Grant.

    The European Research Council (ERC) has awarded scientist Andrea Cerutti, an IMIM researcher and ICREA professor, an advanced grant, with funding of 2 million euros over a five-year period. The objective of the ERC Advanced Grant is to support excellent research projects in the field of science, which are highly innovative and led by prominent researchers with renowned international prestige, who may be from any EU member state or associated country.

    Més informació "Andrea Cerutti obtains the ERC Advanced Grant."

  • 01/02/2012 - Institutional news

    MARBiobanc obtains the Quality Management System UNE – EN ISO 9001:2008 certification.

    The MARBiobanc or Biobank of the Parc de Salut Mar is an infrastructure supporting research whose main mission is to ensure quality, traceability and safety in the storage of biological samples from the Parc de Salut Mar used for research. This certification is an acknowledgement of the task performed over the two past years by the staff working at IMIM’s Biobank and at the Hospital del Mar to provide the Biobank with an organizational infrastructure and equipment.

    Més informació "MARBiobanc obtains the Quality Management System UNE – EN ISO 9001:2008 certification."

Contact

Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)

Tel:
(+34) 93 316 06 80

Doctor Aiguader, 88
08226 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact